Translate page

  • Presentations from the EHA2022 Congress

  • EHA 2022: Mechanisms of disease progression in chronic myeloid leukemia (S. Tiong Ong)

  • EHA 2022: Non-BCR-ABL1 biomarkers of prognosis in CML (Shady Awad)

  • COLT Meeting 2019: CML related topics

  • COLT Meeting 2019: The CML frontier

        Collage Wesseling Sweet 2

    Panel of experts:

    Professor Steve Wesselingh
    South Australia Health and Medical Research Institute, Adelaide (Australia)

    Dr Kendra Sweet
    Haematologist at the MOFFITT Cancer Center and Research Institute, Tampa (USA)

     

    Program:
    COVID-19 vaccines overview: (Steve Wesselingh)

    • Overview of COVID-19 vaccines
    • Vaccine safety
    • Vaccine effectiveness
    • Vaccine variants
    • Vaccine persistence
    • Vaccines and immunocompromised people
    • Open questions

    COVID-19 vaccines for patients with CML (Kendra Sweet)

    • Experience with CML patients infected by COVID-19
    • COVID-19 vaccines assessibility for patients with CML
    • Experience with COVID-19 vaccines in patients with CML
    • Recommendations for patients with CML related to COVID-19 vaccines
    • Patients' perspectives on COVID-19 vaccines

    Q&A Session